Can Omega-3 Fatty Acids Support Kidney Health in Diabetes?
This review looked at existing research—both lab studies and human trials—examining how polyunsaturated fatty acids (PUFAs), including omega-3s, relate to diabetic kidney disease (DKD), a common complication of diabetes that can worsen over time despite standard treatments.
Across the studies summarized, PUFA supplementation was associated with lower blood pressure, improved cholesterol and triglyceride levels, and reduced markers of kidney injury, protein loss in urine, and inflammation. Some research also pointed to less structural kidney damage, such as scarring and thickening of kidney filtering structures, though not every study found these benefits.
The authors concluded that PUFA supplementation appears to be a reasonable dietary approach worth exploring for people with diabetic kidney disease, with no safety concerns identified. However, they noted that the available studies vary widely in design and quality, and larger, more consistent research is still needed to confirm how strong and reliable these effects really are.
What this means for you
For adults managing diabetes, this review suggests omega-3 and other polyunsaturated fats have been studied for their potential connection to kidney-related markers like blood pressure, cholesterol, and inflammation—but the evidence is still developing, so this should be viewed as an area of ongoing research rather than a proven solution.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolSource
Current nutrition reports · 2026-09-17 · DOI: 10.1007/s13668-026-00800-1
Read the original source ↗This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.